MY171947A - Method of preparing a muscadine pomace extract - Google Patents

Method of preparing a muscadine pomace extract

Info

Publication number
MY171947A
MY171947A MYPI2015703087A MYPI2015703087A MY171947A MY 171947 A MY171947 A MY 171947A MY PI2015703087 A MYPI2015703087 A MY PI2015703087A MY PI2015703087 A MYPI2015703087 A MY PI2015703087A MY 171947 A MY171947 A MY 171947A
Authority
MY
Malaysia
Prior art keywords
extracts
anthocyanins
grapes
extract
juice
Prior art date
Application number
MYPI2015703087A
Inventor
Teodoro T Ianiro
Laurel A Fisher
William J Mergens
Original Assignee
Shaklee Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US13/828,707 external-priority patent/US9173916B2/en
Application filed by Shaklee Corp filed Critical Shaklee Corp
Publication of MY171947A publication Critical patent/MY171947A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/35—Caprifoliaceae (Honeysuckle family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/45—Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
    • A61K36/704—Polygonum, e.g. knotweed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Hospice & Palliative Care (AREA)
  • Emergency Medicine (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Rheumatology (AREA)

Abstract

Muscadine grape extracts are disclosed that have antioxidant properties. The extracts are a mixture of extracts from bronze and purple muscadine grapes that unexpectedly increase the solubility of ellagic acid in the mixture. Solvent extracts are obtained in some examples by water extracting the pomaces of the grapes from which the juice has substantially been removed. Further surprising increases in ellagic acid solubility can also be obtained by adding an additional source of anthocyanins to the extract, for example by including in the composition an extract of whole purple muscadine grapes from which substantial amounts of the juice have not been removed. Other additional sources of anthocyanins include blueberries, blackberries and raspberries; the additional source of anthocyanins can be obtained from a fruit processing waste stream to increase the efficiency of the production process.
MYPI2015703087A 2013-03-14 2014-03-12 Method of preparing a muscadine pomace extract MY171947A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13/828,707 US9173916B2 (en) 2008-07-31 2013-03-14 Method of preparing a muscadine pomace extract

Publications (1)

Publication Number Publication Date
MY171947A true MY171947A (en) 2019-11-08

Family

ID=51625227

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI2015703087A MY171947A (en) 2013-03-14 2014-03-12 Method of preparing a muscadine pomace extract

Country Status (10)

Country Link
JP (1) JP6445518B2 (en)
KR (1) KR20150131270A (en)
CN (1) CN105188419B (en)
CA (1) CA2904636C (en)
HK (1) HK1219209A1 (en)
MX (1) MX366664B (en)
MY (1) MY171947A (en)
PH (1) PH12015501949A1 (en)
TW (1) TWI621444B (en)
WO (1) WO2014159677A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7241483B2 (en) * 2018-07-23 2023-03-17 株式会社ノエビア skin composition

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3283553B2 (en) * 1991-12-10 2002-05-20 株式会社創研 Cosmetics
US6190716B1 (en) * 1999-02-17 2001-02-20 Scott O. Galbreath, Jr. Method for preparing a grape derived product
JP5010077B2 (en) * 2001-09-05 2012-08-29 ライオン株式会社 Ellagic acid dispersion and composition for external use
US20040234671A1 (en) * 2003-05-20 2004-11-25 Ector Betty J. Houston Method and system for processing muscadine grape pomace
US20060024392A1 (en) * 2004-04-20 2006-02-02 The University Of Maryland Compositions and methods for enhancing the effectiveness of a chemotherapeutic agent
NZ594596A (en) * 2006-02-10 2011-10-28 Mannatech Inc All natural multivitamin and multimineral dietary supplement formulations for enhanced absorption and biological utilization
KR20100014799A (en) * 2007-01-17 2010-02-11 엔베쎄 뉴트라쇠틱 비지니스 컨썰팅 Anti-oxidant dietary composition containing fruits and vegetables, method for preparing the same and use of the composition
EP2033526A1 (en) * 2007-09-07 2009-03-11 Probelte Pharma, S.A. Nutritional products comprising pomegranate extracts containing ellagitannins and their use
CA2732306C (en) * 2008-07-31 2017-02-28 Shaklee Corporation Muscadine compositions with improved anti-oxidant activity
US9173916B2 (en) * 2008-07-31 2015-11-03 Shaklee Corporation Method of preparing a muscadine pomace extract
TWI484918B (en) * 2008-07-31 2015-05-21 Shaklee Corp Method of preparing a muscadine pomace extract
WO2010014873A2 (en) * 2008-07-31 2010-02-04 Shaklee Corporation Method of preparing a muscadine pomace extract
WO2011155505A1 (en) * 2010-06-09 2011-12-15 花王株式会社 Manufacturing method for polyphenol composition

Also Published As

Publication number Publication date
TW201501721A (en) 2015-01-16
JP2016518110A (en) 2016-06-23
TWI621444B (en) 2018-04-21
MX366664B (en) 2019-07-18
PH12015501949A1 (en) 2016-01-11
HK1219209A1 (en) 2017-03-31
WO2014159677A1 (en) 2014-10-02
MX2015012676A (en) 2016-02-16
CA2904636C (en) 2021-05-04
JP6445518B2 (en) 2018-12-26
CN105188419B (en) 2018-06-19
CN105188419A (en) 2015-12-23
CA2904636A1 (en) 2014-10-02
KR20150131270A (en) 2015-11-24

Similar Documents

Publication Publication Date Title
PH12018500093A1 (en) Process for the production of cannabidiol and delta-9-tetrahydrocannabinol
EA201890883A1 (en) VACUUM DISTILLATION FOR ENRICHING CANNABIDIOL
AU2015217822A8 (en) Method for producing vitamin E-enriched, especially tocotrienol-enriched, compositions from natural oils
UA109652C2 (en) METHODS OF EXTRACTION AND SEPARATION OF CELLULOSE MATERIAL COMPONENTS
MX2016002288A (en) Oil extraction aids in grain processing.
PH12017502056A1 (en) A biostimulant formulation for improving plant growth and uses thereof
MX341686B (en) Composition containing scirpusin b, and process for producing composition containing scirpusin b.
MX2018002830A (en) Process for the extraction of silica.
EP3484459A4 (en) Decarboxylation of cannabidiolic acid in hemp biomass&hemp extract
GR1007894B (en) Method for the production of meat-based products with oil addition
MD588Y (en) Process for producing red wine
PH12015501949A1 (en) Method for preparing a muscadine pomace extract
MX2015012841A (en) Bioactive compositions from fruit and methods for their production.
MX2016001720A (en) Surface-modified metal colloids and production thereof.
IN2015MU00580A (en)
MX357455B (en) Drying process by micro aspersion and preparation of the hesperidin/cyclodextrin inclusion complex.
RU2010124076A (en) METHOD FOR PRODUCING CHAGA EXTRACTS
PH22015000588U1 (en) PROCESS OF PRODUCING ANTHOCYANIN POWDER FROM PURPLE CORN (Zea mays var. Kculli)
RU2012152178A (en) METHOD FOR PRODUCING ANTI-OXIDATIVE AND ANTI-INFLAMMATORY ACTIVITY PRODUCT
MD4360B1 (en) Process for producing myxoxanthophyll from Spirulina platensis cyanobacterium biomass
GR1008312B (en) Production of an alcoholic fig-based drink called souma
EA201501159A1 (en) METHOD FOR OBTAINING A GRANULATED COMPOSITION AND A PRODUCT OBTAINED BY THIS METHOD
MD4576B1 (en) Process for producing an anthocyanin concentrate from grapes
PL415207A1 (en) Method for separating acrylic acid from the post-production sewage
Bowen Antioxidative Effect of Alcoholic Extract from Chlorella